VOYG:NYSEVoyager Technologies, Inc. Analysis
Data as of 2026-05-09 - not real-time
$29.74
Latest Price
8/10Risk
Risk Level: High
Executive Summary
VOYG is trading at $29.74, comfortably above its 20‑day SMA ($28.68) and 50‑day SMA ($27.53), but below the 200‑day SMA ($28.98) and the identified resistance at $33.94. Technicals show a neutral trend with an RSI of 56.6 and a bearish MACD divergence, while price volatility is extremely high at ~80% over the past 30 days and a beta of 2.95 indicates amplified market moves.
Fundamentally, the company reports negative earnings (trailing EPS -$3.06), a steep operating loss margin, and a substantial debt‑to‑equity ratio of 121%, yet analysts remain bullish, citing a 26% upside potential and a "Buy" consensus driven by recent NASA contract wins and an ISS mission management award that have sparked short‑term price rallies.
Fundamentally, the company reports negative earnings (trailing EPS -$3.06), a steep operating loss margin, and a substantial debt‑to‑equity ratio of 121%, yet analysts remain bullish, citing a 26% upside potential and a "Buy" consensus driven by recent NASA contract wins and an ISS mission management award that have sparked short‑term price rallies.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Recent NASA contract and ISS mission news driving price momentum
- Price above short‑term moving averages providing technical support
- High beta and volatility suggesting rapid upside if sentiment stays positive
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Analyst consensus (10 analysts) and target median price of $39 indicating ~30% upside
- Strategic positioning in defense and commercial space markets with long‑term contracts
- Current support level at $24.82 offering downside cushion despite cash‑flow deficits
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Sustained negative cash flow and high leverage raise solvency concerns
- Sector growth prospects in aerospace & defense may eventually translate to profitability
- Elevated beta and volatility imply that price swings could be severe over extended horizons
Key Metrics & Analysis
Financial Health
Revenue Growth2.10%
Profit Margin-72.90%
P/E Ratio-25.1
ROE-54.10%
ROA-11.10%
Debt/Equity121.47
P/B Ratio4.6
Op. Cash Flow$-86301000
Free Cash Flow$-229552256
Industry P/E29.9
Technical Analysis
TrendNeutral
RSI56.6
Support$24.82
Resistance$33.94
MA 20$28.68
MA 50$27.53
MA 200$28.98
MACDBearish
VolumeStable
Fear & Greed Index90.73
Valuation
Target Price$37.50
Upside/Downside26.09%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta2.95
Volatility79.65%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.